Serum Level of Macrophage Migration Inhibitory Factor in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease

The study investigated serum levels of Macrophage Migration Inhibitory Factor (MIF) in Egyptian patients with alopecia areata (AA) and found significantly higher MIF levels in AA patients compared to healthy controls. There was a positive correlation between MIF levels and the clinical severity of AA, with higher levels associated with more severe cases. Additionally, MIF levels negatively correlated with patient age and positively with disease duration. These findings suggested that MIF could be a crucial biomarker for assessing AA severity and a potential target for future therapies.